cath lab cardiovascular surgery clinical trial/study scai heart attack

The Society for Cardiovascular Angiography and Interventions (SCAI) assembled  a panel that has proposed new criteria for identifying patients who experience a heart attack after coronary angioplasty or bypass surgery. The new criteria and their implications for patient care are detailed in an expert consensus document e-published today in Catheterization and Cardiovascular Interventions (CCI) and the Journal of the American College of Cardiology (JACC).

The U.S. Food and Drug Administration (FDA) has cleared Sotera Wireless Inc.’s patented continuous non-invasive blood pressure (cNIBP) technology, a new feature of the ViSi Mobile wireless patient monitoring system. For the first time clinicians can continuously monitor all patient vital signs, including beat-to-beat blood pressure, without the use of a catheter or blood pressure cuff.

 The Boston Scientific OffRoad Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages in the major arteries that supply blood to the legs. These blockages, called chronic total occlusions (CTOs), are often associated with peripheral artery disease (PAD). The data from the Re-ROUTE clinical trial were reported in a late-breaking clinical trial session at the Vascular Interventional Advances Conference (VIVA) in Las Vegas.

AccessClosure Inc. announced an exclusive agreement with Ostial Corp. to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The system is designed to help overcome the challenges of aorto-ostial stenting and complements the Mynx product family of vascular closure devices.

CardioDx Inc. announced results of two studies indicating that Corus CAD, a blood-based gene expression test, may help reduce unnecessary cardiac testing and costs by aiding clinician decision-making in the evaluation of women with obstructive coronary artery disease (CAD) symptoms. The studies were presented at The North American Menopause Society (NAMS) 2013 Annual Meeting in Dallas, Texas.

heart disease, breast cancer, HDL

High levels of high-density lipoprotein (HDL) have been linked to increased breast cancer risks and enhanced cancer aggressiveness in animal experiments.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now